
Journal of Medicinal Chemistry p. 2789 - 2793 (1995)
Update date:2022-07-31
Topics:
Chiba, Peter
Burghofer, Sabine
Richter, Elisabeth
Tell, Barbara
Moser, Andrea
Ecker, Gerhard
A series of <(o-acylaryl)oxy>propanolamines have been prepared and evaluated for multidrug resistance-reverting activity in a human tumor cell model.Structure-activity relationship studies indicate that the phenylpropiophenone moiety as well as the substitution pattern at the nitrogen atom is crucial for activity of the compounds.Incorporation of the ether oxygen into a benzofuran substructure, which renders the compound an arylethanolamine, decreased biologic activity.Highest activity could be observed with the arylpiparazines 4f-h, which not only completely restored daunomycin sensitivity but also showed moderate activity in restoring etoposide toxicity.
View MoreWuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Contact:17316303296
Address:240 Amboy Ave
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Hefei Highzone Fine Chemical S&T CO.,LTD
Contact:86-0551-63663560
Address:room 1801 NO. 24 Shuguang RD.
Heliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Doi:10.1021/ma048091y
(2005)Doi:10.1002/ejoc.201200647
(2012)Doi:10.1039/jr9540002537
(1954)Doi:10.1007/BF00912678
(1950)Doi:10.1021/jo00160a040
(1983)Doi:10.1021/ja01199a035
(1947)